[46] Chaves MM, Lee SH,

Kamenyeva O, Ghosh K, Peters NC, Sacks D. The role of dermis resident macrophages and their interaction with neutrophils in the early establishment of *Leishmania major* infection transmitted by sand fly bite. PLoS Pathogens. 2020;**16**:e1008674. DOI: 10.1371/journal.ppat.1008674

[47] Romano A, Carneiro MBH, Doria NA, Roma EH, Ribeiro-Gomes FL, Inbar E, et al. Divergent roles for Ly6C+CCR2+CX3CR1+ inflammatory monocytes during primary or secondary infection of the skin with the intraphagosomal pathogen *Leishmania major*. PLoS Pathogens. 2017;**13**:e1006479

[48] Aga E, Katschinski DM, van Zandbergen G, Laufs H, Hansen B, Müller K, et al. Inhibition of the spontaneous apoptosis of neutrophil granulocytes by the intracellular parasite *Leishmania major*. Journal of Immunology. 2002;**169**:898-905. DOI: 10.4049/jimmunol.169.2.898

[49] Novais FO, Santiago RC, Báfica A, Khouri R, Afonso L, Borges VM, et al. Neutrophils and macrophages cooperate in host resistance against *Leishmania braziliensis* infection. Journal of Immunology. 2009;**183**:8088-8098. DOI: 10.4049/jimmunol.0803720

[50] Ribeiro-Gomes FL, Roma EH, Carneiro MBH, Doria NA, Sacks DL, Peters NC. Site-dependent recruitment of inflammatory cells determines the effective dose of *Leishmania major*. Infection and Immunity. 2014;**82**:2713-2727. DOI: 10.1128/IAI.01600-13

[51] Tacchini-Cottier F, Zweifel C, Belkaid Y, Mukankundiye C, Vasei M, Launois P, et al. An immunomodulatory function for neutrophils during the induction of a CD4 + Th2 response in BALB/c mice infected with *Leishmania major*. Journal of Immunology. 2000;**165**:2628-2636. DOI: 10.4049/ jimmunol.165.5.2628

[52] Charmoy M, Megnekou R, Allenbach C, Zweifel C, Perez C, Monnat K, et al. Leishmania major induces distinct neutrophil phenotypes in mice that are resistant or susceptible to infection. Journal of Leukocyte Biology. 2007;**82**:288-299. DOI: 10.1189/ jlb.0706440

*Protective and Pathogenic Immune Responses to Cutaneous Leishmaniasis DOI: http://dx.doi.org/10.5772/intechopen.101160*

[53] Sousa LMA, Carneiro MBH, Resende ME, Martins LS, dos Santos LM, Vaz LG, et al. Neutrophils have a protective role during early stages of *Leishmania amazonensis* infection in BALB/c mice. Parasite Immunology. 2014;**36**:13-31. DOI: 10.1111/pim.12078

[54] Conceição J, Davis R, Carneiro PP, Giudice A, Muniz AC, Wilson ME, et al. Characterization of neutrophil function in human cutaneous Leishmaniasis caused by *Leishmania braziliensis*. PLoS Neglected Tropical Diseases. 2016;**10**:e0004715. DOI: 10.1371/journal.pntd.0004715

[55] Tavares NM, Araújo-Santos T, Afonso L, Nogueira PM, Lopes UG, Soares RP, et al. Understanding the mechanisms controlling leishmania amazonensis infection in vitro: The role of LTB4 derived from human neutrophils. The Journal of Infectious Diseases. 2014;**210**:656-666. DOI: 10.1093/ infdis/jiu158

[56] Tavares N, Afonso L, Suarez M, Ampuero M, Prates DB, Araújo-Santos T, et al. Degranulating neutrophils promote leukotriene B 4 production by infected macrophages to kill *Leishmania amazonensis* parasites. Journal of Immunology. 2016;**196**:1865- 1873. DOI: 10.4049/jimmunol.1502224

[57] Goncalves R, Zhang X, Cohen H, Debrabant A, Mosser DM. Platelet activation attracts a subpopulation of effector monocytes to sites of *Leishmania major* infection. The Journal of Experimental Medicine. 2011;**208**:1253- 1265. DOI: 10.1084/jem.20101751

[58] Olekhnovitch R, Ryffel B, Müller AJ, Bousso P. Collective nitric oxide production provides tissue-wide immunity during Leishmania infection. The Journal of Clinical Investigation. 2014;**124**:1711-1722. DOI: 10.1172/ JCI72058

[59] Novais FO, Nguyen BT, Beiting DP, Carvalho LP, Glennie ND, Passos S, et al. Human classical monocytes control the intracellular stage of *Leishmania braziliensis* by reactive oxygen species. The Journal of Infectious Diseases. 2014;**209**:1288-1296. DOI: 10.1093/ infdis/jiu013

[60] Scharton TM, Scott P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to *Leishmania major* in mice. The Journal of Experimental Medicine. 1993;**178**:567- 577. DOI: 10.1084/jem.178.2.567

[61] Wei X, Charles IG, Smith A, Ure J, Feng G, Huang F, et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 1995;**375**: 408-411. DOI: 10.1038/375408a0

[62] Roma EH, Macedo JP, Goes GR, Gonçalves JL, De CW, Cisalpino D, et al. Impact of reactive oxygen species (ROS) on the control of parasite loads and inflammation in *Leishmania amazonensis* infection. Parasites & Vectors. 2016;**9**:193. DOI: 10.1186/ s13071-016-1472-y

[63] Gantt KR, Goldman TL, McCormick ML, Miller MA, Jeronimo SMB, Nascimento ET, et al. Oxidative responses of human and murine macrophages during phagocytosis of *Leishmania chagasi*. Journal of Immunology. 2001;**167**:893- 901. DOI: 10.4049/jimmunol.167.2.893

[64] Tibúrcio R, Nunes S, Nunes I, Rosa Ampuero M, Silva IB, Lima R, et al. Molecular aspects of dendritic cell activation in Leishmaniasis: An immunobiological view. Frontiers in Immunology. 2019;**10**:227. DOI: 10.3389/ fimmu.2019.00227

[65] Sato N, Ahuja SK, Quinones M, Kostecki V, Reddick RL, Melby PC, et al. Cc chemokine receptor (Ccr)2 is required for langerhans cell migration and localization of T Helper Cell Type 1 (Th1)-inducing dendritic cells. The

Journal of Experimental Medicine. 2000;**192**:205-218. DOI: 10.1084/ jem.192.2.205

[66] Carvalho AM, Guimarães LH, Costa R, Saldanha MG, Prates I, Carvalho LP, et al. Impaired Th1 response is associated with therapeutic failure in patients with cutaneous Leishmaniasis caused by *Leishmania braziliensis*. The Journal of Infectious Diseases. 2021;**223**:527-535. DOI: 10.1093/infdis/jiaa374

[67] de Lima CMF, Magalhães AS, Costa R, Barreto CC, Machado PRL, Carvalho EM, et al. High antileishmania IgG antibody levels are associated with severity of mucosal Leishmaniasis. Frontiers in Cellular and Infection Microbiology. 2021;**11**:652956. DOI: 10.3389/fcimb.2021.652956

[68] Christensen SM, Belew AT, El-Sayed NM, Tafuri WL, Silveira FT, Mosser DM. Host and parasite responses in human diffuse cutaneous leishmaniasis caused by *L. amazonensis*. PLoS Neglected Tropical Diseases. 2019;**13**:e0007152. DOI: 10.1371/journal. pntd.0007152

[69] Kostka SL, Knop J, Konur A, Udey MC, von Stebut E. Distinct roles for IL-1 receptor type I signaling in early versus established *Leishmania major* infections. Journal of Investigative Dermatology. 2006;**126**(7):1582-1589. Available from: https://linkinghub. elsevier.com/retrieve/pii/ S0022202X15329900

[70] Rutz S, Eidenschenk C, Ouyang W. IL-22, not simply a Th17 cytokine. Immunological Reviews. 2013;**252**:116- 1132. DOI: 10.1111/imr.12027

[71] Araujo Flores GV, Sandoval Pacheco CM, Sosa Ochoa WH, Gomes CMC, Zúniga C, Corbett CP, et al. Th17 lymphocytes in atypical cutaneous leishmaniasis caused by *Leishmania* (L.) *infantum* chagasi in

Central America. Parasite Immunology. 2020;**42**:e12772. DOI: 10.1111/pim.12772

[72] Alexander J, Brombacher F. T Helper1/T Helper2 cells and resistance/ susceptibility to Leishmania infection: Is this paradigm still relevant? Frontiers in Immunology. 2012;**3**:80. DOI: 10.3389/ fimmu.2012.00080

[73] Voronov E, Dotan S, Gayvoronsky L, White RM, Cohen I, Krelin Y, et al. IL-1-induced inflammation promotes development of leishmaniasis in susceptible BALB/c mice. International Immunology. 2010;**22**(4):245-257

[74] Malek TR. The main function of IL-2 is to promote the development of T regulatory cells. Journal of Leukocyte Biology. 2003;**74**:961-965. DOI: 10.1189/ jlb.0603272

[75] Oliveira PRS, Dessein H, Romano A, Cabantous S, de Brito MEF, Santoro F, et al. IL2RA genetic variants reduce IL-2–dependent responses and aggravate human cutaneous Leishmaniasis. Journal of Immunology. 2015;**194**:2664-2672. DOI: 10.4049/jimmunol.1402047

[76] Biedermann T, Zimmermann S, Himmelrich H, Gumy A, Egeter O, Sakrauski AK, et al. IL-4 instructs TH1 responses and resistance to *Leishmania major* in susceptible BALB/c mice. Nature Immunology [Internet]. 2001;**2**(11):1054-1060. Available from: http://www.nature.com/articles/ni725

[77] Poudel B, Yorek MS, Mazgaeen L, Brown SA, Kanneganti T-D, Gurung P. Acute IL-4 governs pathogenic T cell responses during *Leishmania major* infection. ImmunoHorizons. 2020;**4**:546-560. DOI: 10.4049/ immunohorizons.2000076

[78] Titus RG, Dekrey GK, Morris RV, Soares MBP. Interleukin-6 deficiency influences cytokine expression in susceptible BALB mice infected with

*Protective and Pathogenic Immune Responses to Cutaneous Leishmaniasis DOI: http://dx.doi.org/10.5772/intechopen.101160*

Leishmania major but does not alter the outcome of disease. Infection and Immunity. 2001;**69**:5189-5192. DOI: 10.1128/IAI.69.8.5189-5192.2001

[79] Laufs H, Müller K, Fleischer J, Reiling N, Jahnke N, Jensenius JC, et al. Intracellular survival of *Leishmania major* in neutrophil granulocytes after uptake in the absence of heat-labile serum factors. Infection and Immunity. 2002;**70**:826-835. DOI: 10.1128/ IAI.70.2.826-835.2002

[80] Buxbaum LU, Scott P. Interleukin 10- and Fcγ receptor-deficient mice resolve *Leishmania mexicana* lesions. Infection and Immunity. 2005;**73**:2101- 8. DOI: 10.1128/IAI.73.4.2101-2108.2005

[81] Park AY, Hondowicz BD, Scott P. IL-12 is required to maintain a Th1 response during *Leishmania major* infection. Journal of Immunology [Internet]. 2000;**165**(2):896-902. Available from: http://www.jimmunol. org/lookup/doi/10.4049/jimmunol. 165.2.896

[82] Matthews DJ, Emson CL, McKenzie GJ, Jolin HE, Blackwell JM, McKenzie ANJ. IL-13 is a susceptibility factor for *Leishmania major* infection. Journal of Immunology [Internet]. 2000;**164**(3):1458-1462. Available from: http://www.jimmunol.org/lookup/ doi/10.4049/jimmunol.164.3.1458

[83] Banerjee A, Bhattacharya P, Joshi AB, Ismail N, Dey R, Nakhasi HL. Role of pro-inflammatory cytokine IL-17 in Leishmania pathogenesis and in protective immunity by Leishmania vaccines. Cellular Immunology [Internet]. 2016;**309**:37-41. Available from: https://linkinghub.elsevier.com/ retrieve/pii/S0008874916300533

[84] Lopez Kostka S, Dinges S, Griewank K, Iwakura Y, Udey MC, von Stebut E. IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice. Journal of Immunology [Internet]. 2009;**182**(5):3039-3046. Available from: http://www.jimmunol.org/lookup/ doi/10.4049/jimmunol.0713598

[85] Monteforte GM, Takeda K, Rodriguez-Sosa M, Akira S, David JR, Satoskar AR. Genetically resistant mice lacking IL-18 gene develop Th1 response and control cutaneous *Leishmania major* infection. Journal of Immunology [Internet]. 2000;**164**(11):5890-5893. Available from: http://www.jimmunol. org/lookup/doi/10.4049/ jimmunol.164.11.5890

[86] Gimblet C, Loesche MA, Carvalho L, Carvalho EM, Grice EA, Artis D, et al. IL-22 protects against tissue damage during cutaneous leishmaniasis. PLoS One. 2015

[87] Anderson CF, Stumhofer JS, Hunter CA, Sacks D. IL-27 regulates IL-10 and IL-17 from CD4 + cells in nonhealing *Leishmania major* infection. Journal of Immunology[Internet]. 2009;**183**(7):4619-4627. Available from: http://www.jimmunol.org/lookup/ doi/10.4049/jimmunol.0804024

[88] Farias Amorim CO, Novais F, Nguyen BT, Nascimento MT, Lago J, Lago AS, et al. Localized skin inflammation during cutaneous leishmaniasis drives a chronic, systemic IFN-γ signature. PLoS Neglected Tropical Diseases. 2021;**15**:e0009321 10.1371/journal.pntd.0009321

[89] Pinheiro RO, Rossi-Bergmann B. Interferon-gamma is required for the late but not early control of *Leishmania amazonensis* infection in C57Bl/6 mice. Memórias do Instituto Oswaldo Cruz [Internet]. 2007;**102**(1):79-82. Available from: http://www.scielo.br/scielo. php?script=sci\_arttext&pid=S0074- 02762007000100013&lng=en&tlng=en

[90] Fromm PD, Kling JC, Remke A, Bogdan C, Körner H. Fatal leishmaniasis in the absence of TNF despite a strong Th1 response. Frontiers in Microbiology.
